Navigation Links
Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients
Date:2/19/2009

"Horphag has 12 ongoing research works on Pycnogenol(R) in the pipeline and in December 2008, another study was published, demonstrating significant lowering of the inflammatory marker, C-reactive protein (CRP) in osteoarthritis patients post intake of Pycnogenol(R)," notes Pasricha. "These key research initiatives demonstrate the company's accomplishments that have surpassed all similar efforts undertaken by other research institutes on Pycnogenol(R)."

Pycnogenol(R)'s versatility is obvious in its capacity to not only improve blood flow, blood lipid profile, and strengthening blood capillary walls but also to lower cholesterol, normalize blood pressure, and prevent thrombosis. It reduces blood glucose level and carbohydrate absorption, thereby preventing diabetic syndrome, diabetic ulcers, and muscle cramps.

Its antioxidant properties and anti photo-aging potencies make it ideal for oral and topical skin care formulas, while its capability to bind collagen and elastin improves skin elasticity and reduces pigmentation. Its immune modulation profile makes it suitable for combating asthma and hay fever, thereby promoting respiratory health.

Evidently, Pycnogenol(R) provides a reliable and clinically tested nutritional option of addressing a comprehensive range of health issues across the food and beverage ingredients and pharmaceutical industries. Moreover, it is one of the few ingredients that conform to bioavailability, metabolization, excretion, and complete pharmacokinetics in humans.

"Pycnogenol(R) has set a new benchmark for all nutritional ingredients and dietary supplements in terms of its versatile health benefits, safety data, and research portfolio and has the highest probability of becoming an undisputed industry standard in the near future," observes Pasricha. "In addition, Pycnogenol(R) has received Kosher certification for quality and generally recognized as safe (GRAS) approval f
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing
2. Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation
3. Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe
4. Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets
5. Frost & Sullivan - Consumer Preference for Healthy Bakery
6. Frost & Sullivan Finds Compliance Requirements Drive the Healthcare Security Boom
7. Frost & Sullivan Bestows Product Line Strategy Leadership Award to VTS Medical Systems, LLC
8. Frost & Sullivan Forecasts Increased Demand for Portable and PC-based Ultrasound Units in Eastern Europe
9. Verified Physicians a Must for Ensuring Quality Data From Online Surveys, Finds Frost & Sullivan
10. Ready-To-Use Products Spur the European Tissue Sealants and Topical Hemostats Markets, Says Frost & Sullivan
11. Frost & Sullivan to Host Analyst Briefing on the European Orphan Diseases Market: Niche-Busters - An Attractive Future?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... DiscountFurnaceFilter.com, the number one solution for homeowner’s indoor ... Saver kit at an exceptional price. The 5-2-1 Compressor Saver ... conditioning unit during start up, saving wear and tear on ... burn out. , The 5-2-1 Compressor Saver works ... less power to start and drastically reduces the rush of ...
(Date:6/19/2013)... Beverly Hills, CA (PRWEB) June 19, 2013 ... Beverly Hills, permits some patients to quit using drugs ... Kern and Adi Jaffe, the founders of Alternatives, believe ... “hit Bottom” before they enter treatment and that this ... that 22 million people in the United States need ...
(Date:6/19/2013)... City, MO (PRWEB) June 19, 2013 Kansas City ... part of Main Street Day . A section of Main ... pedestrian traffic during the afternoon of the event. The Main ... host the event, which will help Kansas City join the ranks ... used Ciclovia as a tool to foster community vibrancy and active ...
(Date:6/19/2013)... Bellingham, Washington (PRWEB) June 19, 2013 ... before physicians deem it medically necessary, according to ... Maternal and Child Health Journal. The results of ... advocating for more than a decade – that ... care, and maintaining a healthy body weight. Fairhaven ...
(Date:6/19/2013)... June 19, 2013 In 2011, the ... EUR 710 million. Generic drugs form the largest sector, ... value. The pharmaceutical industry is a significant contributor to ... the country’s GDP. Approximately 50% of the total domestic ... pharmaceutical industry. Hemofarm, Galenika and Zdravlje Actavis are key ...
Breaking Medicine News(10 mins):Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 2Health News:Top L.A. Addiction Experts Assert That an Abstinence-Only Approach to Addiction Keeps 85% of Addicts From Seeking Treatment 3Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 2Health News:Main Street Corridor Development Corporation and BikeWalkKC Partner to Host Main Street Day and Kansas City’s First Ciclovia 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 2Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 3Health News:Fairhaven Health's Dr. Amos Grunebaum Says Fertility Awareness Leads to Babies 4Health News:Serbian Pharmaceutical Market Scrutinized by CUBE in Topical Report Now Available at MarketPublishers.com 2
... in March , , DETROIT, June 30 The National ... the blind in the United States, will hold its third March ... City March for Independence is a 5K walk held as part ... place in Detroit this year. Over one thousand blind Americans, ...
... an unmitigated success, welcoming 1012 visitors who left the show impressed ... June 30 A total success. That ... Summit , held for the first time on June 15-16, 2009 ... exhibition welcomed over 1000 key decision-makers in the food industry, in ...
... contribute to solving the world,s major problems over the next five ... special 25th anniversary edition of Issues in Science and Technology ... for science to deliver on its potential to enhance prosperity, security, ... respond. , , Vaclav Smil on the need ...
... medical device company Intelligent Hospital Systems (IH Systems) ... the Computerworld Honors Program Awards Gala on June ... the award in recognition of its RIVA System ... software, robotics and engineering to automate IV preparation ...
... 30 The Renal Physicians Association (RPA) supports Kidney ... in Kidney Care (PEAK) initiative. RPA is a member ... dialysis providers, physicians, manufacturers, and nurses who work together ... The goal of the PEAK campaign is to reduce ...
... found evidence that chronic disease in either a mother ... that are associated with the development of polycystic ovarian ... that brothers of women with PCOS and insulin resistance ... or diabetes, suggesting that factors associated with the condition ...
Cached Medicine News:Health News:Over One Thousand Blind Americans to March in Detroit 2Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 2Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 3Health News:Food Ingredients Industry Leaders Applaud the Launch of Health ingredients South America 4Health News:Articles by Prominent Scientists Featured in 25th Anniversary Issue 2Health News:Intelligent Hospital Systems Receives International Award for Innovative Technology Benefiting Society 2Health News:Polycystic ovarian syndrome: New light on its causes and its effect on brothers 2Health News:Polycystic ovarian syndrome: New light on its causes and its effect on brothers 3Health News:Polycystic ovarian syndrome: New light on its causes and its effect on brothers 4
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ -- Chindex International, Inc. ... healthcare company providing services in China ... Healthcare, a network of private hospitals and affiliated ... its Beijing United Family Rehabilitation Hospital ("BJU Rehab ... the United Family Healthcare ("UFH") network. On June ...
(Date:6/19/2013)... Israel , June 19, 2013 ... phase I study in volunteers, and preliminary results from ... ND0612, were presented at the 2013 International Congress of ... levodopa/carbidopa liquid drug formula under development for continuous administration ... constant levodopa plasma concentrations. ND0612 has been ...
(Date:6/19/2013)... , June 19, 2013  Omnicell, Inc. ... of medication and supply management solutions and analytics ... was named the number one overall pharmacy equipment ... Infrastructure Report. KLAS, a leading independent healthcare research ... equipment vendors in its annual rankings. Omnicell also ...
Breaking Medicine Technology:Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 2Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 3Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 4Chindex International, Inc. Announces Opening of Beijing United Family Rehabilitation Hospital 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 2Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 3Omnicell Named Top Vendor in 2013 KLAS Pharmacy Automation Equipment Rankings 4
... Thomas, McNerney & Partners, LLC, a health care venture ... technology companies, will be relocating its West Coast office ... Pratik Shah, Ph.D. announced the move at BIOCOM,s first ... "Southern California is home to many top-tier scientific ...
... 2011 Healthpoint today announced the launch of a ... Biotherapeutics, along with an updated brandmark and corporate tagline, ... is designed to communicate the company,s commitment to scientific ... contribute to improved outcomes and quality of life for ...
Cached Medicine Technology:Thomas, McNerney & Partners Expands Team and Moves West Coast Office to San Diego 2Healthpoint Launches New Corporate Identity 2Healthpoint Launches New Corporate Identity 3
Specimen mounts are designed to allow for the rotation of the specimen in the Vibratome vice assembly for sectioning at different horizontal orientations....
... provides a convenient reservoir of cooling water for the ... extended period of time or in a location which ... the hot side of the thermoelectric heat pump. ... is adequate to run the 900R for up to ...
Punch set for Advanced Tissue Arrayer, 2.0 mm...
Inquire...
Medicine Products: